Pronounce: tar-LAT-ue-mab
Classification: Bispecific T-cell Engager
Tarlatamab-dlle is a type of medication called a bispecific T-cell engager (BiTE) antibody. This medication helps your body’s T-cells (part of your immune system) target and kill cells that have a certain protein on their surface. Tarlatamab-dlle targets the delta-like ligand 3 (DLL3) protein. DLL3 is found on the surface of cancer cells in certain types of lung cancer.
Tarlatamab-dlle is given by intravenous (IV, into a vein) infusion. The first time you receive this medication, you will receive a smaller dose for the first day. The next doses will be the normal dose if you tolerate the medication. This is called “step-up dosing.” You will receive the first two doses in a hospital. A third dose will be given 7 days later in an outpatient facility, after which you will receive your treatment dose outpatient every two weeks.
For the first 2 doses, your care team will monitor you in the hospital for 22 to 24 hours after the infusion. Following the first two infusions, it is recommended that you and a caregiver stay within 1-hour of an appropriate healthcare setting for a total of 48 hours from the start of the infusion. As your treatment goes on, if tolerated, the length of monitoring time will go down.
You will be given “pre-medications” before each step-up dose of tarlatamab-dlle, including dexamethasone (a steroid). Some patients will need these pre-medications with every dose depending on how they tolerate taralatamab-dlle.
Tell your care team about all the medications you take, including prescription and over-the-counter medications, vitamins, and herbal supplements. You should not drive or operate heavy machinery during treatment with this medication.
There are a number of things you can do to manage the side effects of tarlatamab-dlle. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Cytokine release syndrome (CRS) can happen. This medication activates T-cells, causing them to release many cytokines. The cytokines cause an inflammatory response in the body. This reaction, if left untreated, can be very dangerous. Signs and symptoms may be fever, having a hard time breathing, chills, low blood pressure, fast heart rate, headache, and higher levels of liver enzymes in your blood. Your care team will monitor you closely for CRS while you are receiving this medication. Callyour provider right away if you have any signs or symptoms of CRS so that treatment can be started.
This medication can cause neurologic (brain) toxicities and immune effector cell-associated neurotoxicity. Signs and symptoms may be confusion and feeling more tired than usual. Your care team will monitor you for any changes in your mental status. If you or a loved one notices any changes, call your care team right away.
This medication can cause life-threatening infections, with or without a decrease in white blood cell counts.
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your care team know right away if you have a fever (temperature greater than 100.4°F or 38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal.
Tips for preventing infection:
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. It can cause physical, emotional, and mental exhaustion. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your care team for helpful tips on dealing with this side effect.
Nutrition is an important part of your care. Cancer treatment can affect your appetite and, in some cases, the side effects of treatment can make eating difficult. This medication can cause a metallic taste in your mouth. Ask your oncology care team about nutritional counseling services at your treatment center to help with food choices.
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your oncology care team know if you experience any shortness of breath, difficulty breathing or pain in your chest. If the count gets too low, you may receive a blood transfusion.
This medication can affect the normal levels of electrolytes (sodium, potassium, magnesium, etc.) in your body. Your levels will be monitored using blood tests. If your levels become too low, your care team may prescribe specific electrolytes to be given by IV or taken by mouth. Do not take any supplements without first consulting with your care team.
This medication can cause liver toxicity, which your oncology care team may monitor for using blood tests called liver function tests. Tell your healthcare provider if you notice yellowing of the skin or eyes, your urine appears dark or brown, or you have pain in your abdomen (belly), as these can be signs of liver toxicity.
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your oncology care team know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
Your healthcare provider can recommend medications and other strategies to help relieve pain.
There are several things you can do to prevent or relieve constipation. Include fiber in your diet (fruits and vegetables), drink 8-10 glasses of non-alcoholic fluids a day, and keep active. A stool softener once or twice a day may prevent constipation. If you do not have a bowel movement for 2-3 days, call your healthcare team for suggestions to relieve the constipation.
This medication can cause kidney problems, including an increased creatinine level, which your oncology care team may monitor for using blood tests. Tell your healthcare provider if you have decreased urine output, blood in your urine, swelling in your ankles, or loss of appetite.
Talk to your oncology care team so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy /fatty, spicy or acidic foods (lemons, tomatoes, oranges). Try saltines or ginger ale to lesson symptoms.
Call your oncology care team if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
Important but Less Common Side Effects
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant while on this medication. Effective birth control is necessary for women during treatment and for at least 2 months after treatment. Men should ask your provider about birth control needs. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while receiving this medication or for 2 months after your last dose.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania